The role of protein inhibitor of activated STAT3 and miRNA-18a expressions in breast cancer

• Published in: Egyptian Journal of Medical Human Genetics Vol. 20; no. 1; pp. 1 - 9
• Main Authors: Nomair, Azhar Mohamed, Ahmed, Sanaa Shawky, Nomeir, Hanan Mohamed, El Mansy, Hazem, Mohammed, Ayman Farouk
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 05.10.2019; Springer; Springer Nature B.V; SpringerOpen
• Subjects: Biopsy; Breast cancer; Chromosome aberrations; Cytology; Development and progression; Epidermal growth factor; Epigenetics; ErbB-2 protein; Estrogen; Estrogen receptors; Gene expression; Genes; Genetic aspects; Genetic transcription; Medicine; Medicine & Public Health; MicroRNA; miRNA; miRNA-18a; PIAS3; Polymerase chain reaction; Progesterone; Progesterone receptors; Reverse transcription; Stat3 protein; Tumor suppressor genes; Tumors; Egypt; Epigenetics; PIAS3; Breast cancer; miRNA-18a
• ISSN: 1110-8630; 2090-2441
• DOI: 10.1186/s43042-019-0021-6

Background Breast cancer is a disease characterized by progressive genetic abnormalities including mutations in tumor suppressor genes and oncogenes, as well as other chromosomal abnormalities. Protein inhibitor of activated signal transducer and activator of transcription 3 (PIAS3) is a member of the PIAS family of transcriptional modulators; its expression is altered in many cancers. Micro-ribonucleic acid (miRNA)-18a acts as an oncogene by negatively regulating PIAS3 and thus modulating the expression of signal transducer and activator of transcription 3 (STAT3) target genes. The aim of this work is to examine the expression levels of PIAS3 gene and miRNA-18a in breast cancer tissues and nearby non-tumor tissues. The samples of breast cancer and paired samples of non-cancerous tissue from the same resected breast were obtained from 25 patients undergoing surgery. Full history taking, complete physical examination, pre-operative fine-needle aspiration cytology or ultrasonic (U/S)-guided core biopsy from the breast mass, final surgical biopsy for pathological examination, and routine laboratory investigations were done. Estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) status were evaluated. Total RNA extraction followed by real-time reverse transcription-polymerase chain reaction (RT-PCR) for quantification of PIAS3 mRNA and miRNA-18a expressions was performed. Results The mean value of PIAS3 mRNA fold expression was significantly lower in the tumor group (5.12 ± 9.85) compared to the normal group (8.38 ± 17.10) ( p = 0.040). miRNA-18a fold expression was higher among tumor group (3.5 ± 7.4) than that of normal group (2.5 ± 3), however, it did not reach the level of statistical significance ( p = 0.861). miRNA-18a fold expression had negative significant correlation with PIAS3 mRNA fold expression ( p = 0.018). A significant association was observed between miRNA-18a expression in breast cancer tissues and the pathological grade of the tumor ( p = 0.029). Conclusions The results of this study showed that PIAS3 mRNA and miRNA-18a might be of importance in breast cancer development and pathogenesis, and this may be reflected on the treatment strategies targeting STAT3 pathway. However, further studies with larger sample size are needed to validate these observations.